The world’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease. 

Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International. 

Kingston Mills is a Professor of Experimental Immunology and Biochemistry at Trinity College Dublin and joins Seán to discuss.